Evidence map›Paper›PMID 42801552›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

In Situ Photo‑Crosslinked Functional Bilayer Hydrogel Modulates Local Microenvironment and Remyelination After Optic Nerve Injury.

Tonghe Pan, Yate Huang, Junhao Zhang, Shudong Tian, Zhixing Li, Xuanwen Li, Yanchen Zhang, Dongmei Wang, Sihao Ye, Ming Jin and 4 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Tonghe Pan *Eye Research Center, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Eye Hospital, Wenzhou Medical University, Hangzhou, Zhejiang, China.
Yate Huang *State Key Laboratory of Eye Health, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Junhao ZhangState Key Laboratory of Eye Health, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Shudong TianState Key Laboratory of Eye Health, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.ORCID https://orcid.org/0009-0003-7158-0524
Zhixing LiState Key Laboratory of Eye Health, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Xuanwen LiState Key Laboratory of Eye Health, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Yanchen ZhangState Key Laboratory of Eye Health, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
Dongmei WangEye Research Center, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Eye Hospital, Wenzhou Medical University, Hangzhou, Zhejiang, China.
Sihao YeEye Research Center, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Eye Hospital, Wenzhou Medical University, Hangzhou, Zhejiang, China.
Ming JinState Key Laboratory of Eye Health, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.ORCID https://orcid.org/0000-0003-1962-2777
Neng LingOujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou, Zhejiang, China.ORCID https://orcid.org/0000-0001-8274-4414
Wentao YanState Key Laboratory of Eye Health, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.ORCID https://orcid.org/0000-0002-7647-3002
Kaihui NanState Key Laboratory of Eye Health, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.ORCID https://orcid.org/0000-0002-6592-1682
Wencan WuEye Research Center, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Eye Hospital, Wenzhou Medical University, Hangzhou, Zhejiang, China.ORCID https://orcid.org/0000-0001-8556-1197

Funding

Key Science and Technology Program of Wenzhou ZY2022021National Key R&D Program of China 2018YFA0701703National Key R&D Program of China 2021YFA1101200National Natural Science Foundation of China 82171048
6 · The paper itself

Abstract

Optic nerve injury often causes irreversible vision loss due to limited self-regeneration capacity, persistent neuroinflammation, and failed remyelination. Current therapies partially promote axonal regeneration but rarely achieve meaningful visual recovery, limited mainly by unstable myelin reconstruction and inadequate injury microenvironment modulation. Here, we developed a photo-crosslinkable bilayer hydrogel system (GO/GI@MPDA-Cle). Its outer layer (GM-Odex) provides strong wet tissue adhesion for optic nerve sheath sealing, while the inner layer (GM-imid) enables sustained local release of drug-loaded nanoparticles (MPDA-Cle) for microenvironment modulation. In Vitro, the system exhibited excellent antioxidant and anti-inflammatory properties and polarized microglia toward an anti‑inflammatory phenotype. In a rat partial optic nerve injury model, the hydrogel protected retinal ganglion cells through local immunomodulation and was associated with improved oligodendrocyte-associated maturation and remyelination-associated repair, accompanied by partial improvement in optic nerve conduction-related function. Transcriptomic analysis further revealed that the treatment downregulated pathways related to inflammation, oxidative stress, and neuronal apoptosis, while upregulating genes involved in neuronal regeneration, axonal growth, and myelination. By integrating physical sealing, immunomodulation, and myelin repair, this study proposes a promising multifunctional strategy for optic nerve injury treatment.

Indexed as

bilayer hydrogelclemastinemesoporous polydopamine nanoparticlesmicroenvironment modulationmyelin preservationoptic nerve injuryRGC protection

Identifiers

PMID42801552
PMCPMC13616303

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.